XML 98 R75.htm IDEA: XBRL DOCUMENT v3.22.4
Equity Compensation Plans and Share-Based Compensation - Restricted Stock Unit Award Activity (Details) - $ / shares
shares in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Outstanding at beginning of year   383 373 357
Underlying Shares - Outstanding at end of year 373 435 383 373
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Outstanding at beginning of year   $ 71.93 $ 77.40 $ 69.13
Weighted-Average Exercise Price - Outstanding at end of year $ 77.40 $ 67.38 $ 71.93 $ 77.40
Performance Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Granted   120 105 238
Underlying Shares - Exercised   0 (91) (117)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Granted   $ 69.78 $ 58.68 $ 78.40
Weighted-Average Exercise Price - Vested   $ 0 $ 72.70 $ 48.25
Vesting period   3 years 3 years  
Time Based Shares        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Granted   60 48 21
Underlying Shares - Exercised   (19) (19) (12)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Granted   $ 69.72 $ 58.68 $ 84.93
Weighted-Average Exercise Price - Vested   $ 70.33 $ 67.86 $ 76.84
Performance-Based Canceled        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Exercised   (109) (18) (114)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Vested   $ 86.86 $ 72.56 $ 84.93
Grant date fair value of replacement performance-based awards $ 72.37      
Time Based Canceled        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]        
Underlying Shares - Exercised   0 (15) 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Weighted-Average Exercise Price - Vested   $ 0 $ 72.49 $ 0